H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
Go back to H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)| (NASDAQ: URGN) | Delayed: 41.17 +0.94 (2.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.23 | 52 Week High | $ | |||
| Open | $40.67 | 52 Week Low | $ | |||
| Day High | $41.87 | P/E | N/A | |||
| Day Low | $40.23 | EPS | $ | |||
| Volume | 176,153 | |||||

